News search

E.g., 09/06/2021
E.g., 09/06/2021
Mª Ángeles Zuriaga, Mirian Díez, Fátima Sánchez-Cabo, Ana Dopazo, José Javier Fuster, Ana Quintas y Jorge de la Barrera.
Research
5 Apr 2021

The study, carried out at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) and the Hospital Universitario Virgen de Arrixaca in Murcia, establishes clonal hematopoiesis as a new cardiovascular risk factor and an important link between aging and cardiovascular disease


Research
29 May 2020

The researcher Alejandro Sánchez Alvarado is one of the greatest experts in the study of the mechanisms involved, cellular and biological, in regeneration in the planaria model

Research
31 Oct 2019

Dr. Miguel Torres, of the Centro Nacional de Investigaciones Cardiovasculares (CNIC), leads a new project that will receive €8 million in funding over 5 years, €1,380,000 of which will be directly managed at the CNIC

De izda. a dcha.: José Antonio Enriquez, María del Mar Muñoz, Fátima Sánchez-Cabo, Luis Jesús Jiménez-Borreguero, Rocío Nieto-Arellano, Andrés González-Guerra, Carlos Torroja, José María Castellanos, y Concepción Jiménez.
Research
3 Apr 2018

The study is published in Science Translational Medicine and was conducted by researchers at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC)

Jesús Vázquez, María Villalba, Sara Cogliati, Marina López, Paula Ortiz, José Antonio Enriquez, Laura Padrón, Elena Bonzón y Enrique Lara.
Research
6 Feb 2018

The calcineurin variant CnAβ1 redirects glucose metabolism to increase production of antioxidant compounds, reducing cardiac hypertrophy and improving heart function

 

Dra. Silvia Martín-Puig y Dr. Miguel Torres
About the CNIC
13 Dec 2017

The project has been set up to examine how and why the capacity to develop new cardiac cells and repair the heart after an acute injury is lost with growth

Publications
27 Aug 2015

Investigadores del CNIC y del H Puerta de Hierro Majadahonda han publicado un trabajo en la revista European Heart Journal en el que han analizado 120 pacientes mayores de 60 años ingresados por descompensación de insuficiencia cardiaca

Publications
12 Mar 2012
Publications
6 Jun 2011

Según los resultados publicados en Circulation, una variante de calcineurina, es capaz de reducir el tamaño del infarto y mejorar la función cardiaca abriendo una nueva vía terapeútica